Related News
China鈥檚 vaccine enters clinical trial
Print Edition
AN Ebola vaccine developed by China has been approved to enter the human test stage, the People’s Liberation Army’s General Logistics Department announced yesterday.
The restructured vaccine, developed by the Academy of Military Medical Sciences, is based on the 2014 mutant gene type and especially targets the strain plaguing west Africa.
The freeze-dried powder form of the vaccine will keep it stable for at least two weeks in temperatures of up to 37 degrees Celsius. This will make it suitable for the tropical west African region, according to a review by 17 experts.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
